Rebecca Over is an Endocrinology/Metabolic physician. OpenAlex indexes 6 publications with 217 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
315 Mlk Jr Way
Tacoma, WA 98405
Telephone
253-627-9122Registry record last updated 8 Mar 2016.
Industry payments
36 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20253 payments
- Janssen Biotech, Inc.Program year20252 payments
- Medtronic, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
48.2%Insulin Analog13.2%Lantus Solostar21%Novolog Flexpen11%Humalog Kwikpen U-10010%Toujeo Max Solostar9%Toujeo Solostar7%Tresiba Flextouch U-1007%Insulin Lispro Kwikpen U-1006%Insulin Lispro6%Humalog Kwikpen U-2005%Tresiba Flextouch U-2005%Humalog5%Fiasp Flextouch3%Novolog3%Basaglar Kwikpen U-1003%Soliqua 100-332%Part D<11 patientsGLP-1 receptor agonist12.2%Ozempic62%Mounjaro26%Trulicity12%Part D≥76 patients+ 8 more classes in this area
Hormonal (systemic)
24.6%l-Thyroxine15.5%Levothyroxine Sodium88%Synthroid11%Levoxyl2%Part D<11 patientsThyroid Hormone Synthesis Inhibitor3.6%Methimazole100%Part D≥43 patients+ 6 more classes in this area
Cardiovascular
19.7%Statin9.3%Atorvastatin Calcium51%Rosuvastatin Calcium32%Pravastatin Sodium7%Simvastatin6%Lovastatin5%Part D<11 patientsACE inhibitor2.4%Lisinopril89%Lisinopril-Hydrochlorothiazide11%Part D<11 patients+ 9 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Age and the Thyrotropin Response to Hypothyroxinemia
The Journal of Clinical Endocrinology & Metabolism
2010 - Effect of male odour on LH secretion and the induction of ovulation in seasonally anoestrous goats
Animal Reproduction Science
1990
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Bartholow Duncan
Universidade Federal do Rio Grande do Sul
Alireza Esteghamati
Tehran University of Medical Sciences
Paul Zimmet
Monash University
André Pascal Kengne
South African Medical Research Council
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”